Heterogeneities in anti-schistosome humoral responses following chemotherapy (Q43901475)

27 November 2017

Heterogeneities in anti-schistosome humoral responses following chemotherapy (English)

1 reference

27 November 2017

1 reference

Mutapi F

1

1 reference

27 November 2017

1 November 2001

1 reference

27 November 2017

Trends in Parasitology

1 reference

27 November 2017

17

1 reference

27 November 2017

11

1 reference

27 November 2017

518-524

1 reference

Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Seeking the ghost of worms past

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Praziquantel: mechanisms of anti-schistosomal activity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Praziquantel: an urgent and exciting challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Immune response in chronic Schistosomiasis haematobium and mansoni. Reversibility of alterations after anti-parasitic treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Specific immunoglobulin measurements related to exposure and resistance to Schistosoma mansoni infection in Sudanese canal cleaners

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

The maturation of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Natural versus drug-induced resistance in Schistosoma mansoni infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Effect of praziquantel on the eggs of Schistosoma mansoni, with a note on the implications for managing central nervous system schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Schistosoma mansoni: chemotherapy of infections of different ages

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Correlations between specific antibody levels and urine egg counts for Schistosoma haematobium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Schistosomiasis vaccine development: progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Gender-dependent patterns of infections and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31–q33

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Familial resemblance in humoral immune response to defined and crude Schistosoma mansoni antigens in an endemic area in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Human IgE responses to Schistosoma mansoni and resistance to reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Inverse association between BCG immunisation and intestinal nematode infestation among HIV-1-positive individuals in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Can eradication of helminthic infections change the face of AIDS and tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Anti-schistosome antibody responses in children coinfected with malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Host-parasite population genetics: a cross-sectional comparison of Bulinus globosus and Schistosoma haematobium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

The strain specificity of vaccination with ultra violet attenuated cercariae of the Chinese strain of Schistosoma japonicum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Molecular cloning and enzymatic expression of the 28-kDa glutathione S-transferase of Schistosoma japonicum: evidence for sequence variation but lack of consistent vaccine efficacy in the murine host

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Humoral immune response of children with chronic schistosomiasis. Isotype recognition of adult worm antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Antigenic variability in Trichuris trichiura populations.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902118-3

7 January 2021

10.1016/S1471-4922(01)02118-3

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11872396